A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA ...

Atropine sulfate 1%; oph soln; contains benzalkonium chloride. Compress lacrimal sac by digital pressure for 2–3 minutes after instillation to avoid excessive systemic absorption. Uveitis: 1–2 ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with ...